{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:11:00Z","timestamp":1790421060371,"version":"4.1.0"},"reference-count":24,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Arsenic trioxide (ATO) has been successfully used as a treatment for acute promyelocytic leukemia (APL) for more than a decade. Here we report a patient with APL who developed a mitochondrial myopathy after treatment with ATO. Three months after ATO therapy withdrawal, the patient was unable to walk without assistance and skeletal muscle studies showed a myopathy with abundant cytoplasmic lipid droplets, decreased activities of the mitochondrial respiratory chain complexes, multiple mitochondrial DNA (mtDNA) deletions, and increased muscle arsenic content. Six months after ATO treatment was interrupted, the patient recovered normal strength, lipid droplets had decreased in size and number, respiratory chain complex activities were partially restored, but multiple mtDNA deletions and increased muscle arsenic content persisted. ATO therapy may provoke a delayed, severe, and partially reversible mitochondrial myopathy, and a long-term careful surveillance for muscle disease should be instituted when ATO is used in patients with APL.<\/jats:p>","DOI":"10.1182\/blood-2011-10-385138","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T04:35:05Z","timestamp":1331958905000},"page":"4272-4274","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["Mitochondrial myopathy caused by arsenic trioxide therapy"],"prefix":"10.1182","volume":"119","author":[{"given":"Andoni","family":"Echaniz-Laguna","sequence":"first","affiliation":[{"name":"D\u00e9partement de Neurologie, H\u00f4pitaux Universitaires, Strasbourg, France;"},{"name":"Inserm U692, Universit\u00e9 de Strasbourg, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Benoilid","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Neurologie, H\u00f4pitaux Universitaires, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Vinzio","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pitaux Universitaires, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc-Matthieu","family":"Fornecker","sequence":"additional","affiliation":[{"name":"Service d'Onco-H\u00e9matologie, H\u00f4pitaux Universitaires, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Lannes","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie, H\u00f4pitaux Universitaires, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Goull\u00e9","sequence":"additional","affiliation":[{"name":"Laboratoire de Toxicologie, Centre Hospitalier, Le Havre, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Broly","sequence":"additional","affiliation":[{"name":"Centre de Biologie et Pathologie, Centre Hospitalier Regional Universitaire Lille, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Mousson de Camaret","sequence":"additional","affiliation":[{"name":"Service des Maladies H\u00e9r\u00e9ditaires du M\u00e9tabolisme, Centre de Biologie Est, Centre Hospitalier Universitaire Lyon, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111807431602400_B1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2005-08-3532","article-title":"Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.","volume":"107","author":"Mathews","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2019111807431602400_B2","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood-2005-10-4006","article-title":"Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia.","volume":"107","author":"Estey","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111807431602400_B3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.2010.32.1067","article-title":"Modern approaches to treating acute promyelocytic leukemia.","volume":"29","author":"Sanz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"24","key":"2019111807431602400_B4","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1182\/blood-2010-11-283598","article-title":"From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia.","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"issue":"9737","key":"2019111807431602400_B5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(10)60481-3","article-title":"Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study.","volume":"376","author":"Argos","year":"2010","journal-title":"Lancet"},{"key":"2019111807431602400_B6","unstructured":"Klaassen\n              CD\n            \n          \n          \n            \n              Klaassen\n              CD\n            \n          \n          Major toxic metals: arsenic.\n          Casarett and Doull's Toxicology: The Basic Science of Poisons\n          2008\n          New York, NY\n          McGraw-Hill Medical\n          936\n          939\n          Revised 7th Ed."},{"issue":"11","key":"2019111807431602400_B7","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1158\/0008-5472.CAN-07-0074","article-title":"Arsenic induced mitochondrial damage and altered mitochondrial oxidative function: implications for genotoxic mechanisms in mammalian cells.","volume":"67","author":"Partridge","year":"2007","journal-title":"Cancer Res"},{"issue":"8","key":"2019111807431602400_B8","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-05-0424","article-title":"Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells.","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"issue":"8929","key":"2019111807431602400_B9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(94)91756-6","article-title":"Myositis with tretinoin.","volume":"344","author":"Miranda","year":"1994","journal-title":"Lancet"},{"issue":"9","key":"2019111807431602400_B10","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","article-title":"Management of acute promyelocytic leukaemia: recommendations from an expert panel on behalf of the European LeukaemiaNet.","volume":"113","author":"Sanz","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111807431602400_B11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1191\/096032799678839509","article-title":"Fatal rhabdomyolysis in arsenic trioxide poisoning.","volume":"18","author":"Fanton","year":"1999","journal-title":"Hum Exp Toxicol"},{"issue":"23","key":"2019111807431602400_B12","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1001\/jama.1989.03430230043020","article-title":"Rhabdomyolysis in fatal arsenic trioxide poisoning.","volume":"262","author":"Sanz","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"2019111807431602400_B13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15563659109038603","article-title":"Acute arsenical myopathy: morphological description.","volume":"29","author":"Fernandez-Sola","year":"1991","journal-title":"J Toxicol Clin Toxicol"},{"issue":"3","key":"2019111807431602400_B14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00294665","article-title":"Germanium myopathy: clinical and experimental pathological studies.","volume":"79","author":"Higuchi","year":"1989","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2019111807431602400_B15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/15287390600755240","article-title":"Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic.","volume":"70","author":"Steinmaus","year":"2007","journal-title":"J Toxicol Environ Health A"},{"issue":"52","key":"2019111807431602400_B16","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1038\/sj.onc.1204953","article-title":"Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437.","volume":"20","author":"Belzacq","year":"2001","journal-title":"Oncogene"},{"issue":"9","key":"2019111807431602400_B17","doi-asserted-by":"crossref","first-page":"e12602","DOI":"10.1371\/journal.pone.0012602","article-title":"Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta-JNK pathway.","volume":"5","author":"Das","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"2019111807431602400_B18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.taap.2006.12.029","article-title":"Arsenic induced apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine.","volume":"220","author":"Santra","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"2019111807431602400_B19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1567-1364.2007.00274.x","article-title":"Arsenic induces caspase and mitochondria mediated apoptosis in Saccharomyces cerevisiae.","volume":"7","author":"Du","year":"2007","journal-title":"FEMS Yeast Res"},{"issue":"7","key":"2019111807431602400_B20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1289\/ehp.0901525","article-title":"Arsenic inhibits myogenic differentiation and muscle regeneration.","volume":"118","author":"Yen","year":"2010","journal-title":"Environ Health Perspect"},{"issue":"3","key":"2019111807431602400_B21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2003.07.009","article-title":"The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review.","volume":"193","author":"Carter","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"issue":"13","key":"2019111807431602400_B22","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/hmg\/6.13.2239","article-title":"Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy.","volume":"6","author":"Shoubridge","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2019111807431602400_B23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ng0797-222","article-title":"Reversal of a mitochondrial DNA defect in human skeletal muscle.","volume":"16","author":"Clark","year":"1997","journal-title":"Nat Genet"},{"key":"2019111807431602400_B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1395.024","article-title":"Mitochondrial DNA mutations and aging.","volume":"1100","author":"Krishnan","year":"2007","journal-title":"Ann N Y Acad Sci"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/18\/4272\/1352935\/zh801812004272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/18\/4272\/1352935\/zh801812004272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:55:23Z","timestamp":1574081723000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/18\/4272\/30096\/Mitochondrial-myopathy-caused-by-arsenic-trioxide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,5,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-385138","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]}}}